Geriatric Medicines Market

Geriatric Medicines Market Report By Therapeutic Category (Analgesic, Anti-Hypertensive, Anti-Diabetic, Anticoagulant, Anti-Depressant), By Condition (Cardiovascular Ailments, Arthritis, Diabetes, Neurological Disorders), By Distribution Channel & Regional Forecast 2021-2031

Analysis of Geriatric Medicines market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Geriatric Medicines Market Size (US$ Mn) and Forecast, by Region, 2021 and 2031

    3.2. Global Geriatric Medicines Market: Market Snapshot

4. Market Overview

    4.1. Global Geriatric Medicines Market Overview

    4.2. Global Geriatric Medicines Market Key Industry Developments

    4.3. Key Industry Events

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Geriatric Medicines Market Revenue Projections (US$ Mn), 2021–2031

    5.7. Geriatric Medicines Market: Mergers & Acquisitions

    5.8. Regulatory Framework

    5.9. Heat Map Analysis - Company

6. Global Geriatric Medicines Market Analysis, by Therapeutic Category

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Geriatric Medicines Market Size and Forecast, by Therapeutic Category

        6.3.1. Analgesic

        6.3.2. Antihypertensive

        6.3.3. Statins

        6.3.4. Antidiabetic

        6.3.5. Proton Pump Inhibitor

        6.3.6. Anticoagulant

        6.3.7. Antipsychotic and Antidepressant 

        6.3.8. Others 

    6.4. Global Geriatric Medicines Market Analysis, by Therapeutic Category

    6.5. Global Geriatric Medicines Market Attractiveness Analysis, by Therapeutic Category

7. Global Geriatric Medicines Market Analysis, by Condition

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Geriatric Medicines Market Size and Forecast, by Condition

        7.3.1. Cardiovascular

        7.3.2. Arthritis

        7.3.3. Diabetes

        7.3.4. Neurological

        7.3.5. Cancer

        7.3.6. Osteoporosis 

        7.3.7. Respiratory

        7.3.8. Others

    7.4. Global Geriatric Medicines Market Analysis, by Condition

    7.5. Global Geriatric Medicines Market Attractiveness Analysis, by Condition

8. Global Geriatric Medicines Market Analysis, by Distribution Channel

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Geriatric Medicines Market Size and Forecast, by Distribution Channel

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Global Geriatric Medicines Market Analysis, by Distribution Channel

    8.5. Global Geriatric Medicines Market Attractiveness Analysis, by Distribution Channel

9. Global Geriatric Medicines Market Analysis, by Region

    9.1. Introduction

    9.2. Key Insights

    9.3. Global Geriatric Medicines Market Size and Forecast , by Region, 2021–2031

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

    9.4. Global Geriatric Medicines Market Analysis, by Region

    9.5. Global Geriatric Medicines Market Attractiveness Analysis, by Region

10. North America Geriatric Medicines Market Analysis

    10.1. North America Geriatric Medicines Market Key Findings

    10.2. North America Geriatric Medicines Market Overview

    10.3. North America Geriatric Medicines Market Size and Forecast, by Therapeutic Category

        10.3.1. Analgesic

        10.3.2. Antihypertensive

        10.3.3. Statins

        10.3.4. Antidiabetic

        10.3.5. Proton Pump Inhibitor

        10.3.6. Anticoagulant

        10.3.7. Antipsychotic and Antidepressant 

        10.3.8. Others

        10.3.9. North America Geriatric Medicines Market Analysis, by Therapeutic Category

    10.4. North America Geriatric Medicines Market Size and Forecast, by Condition

        10.4.1. Cardiovascular

        10.4.2. Arthritis

        10.4.3. Diabetes

        10.4.4. Neurological

        10.4.5. Cancer

        10.4.6. Osteoporosis 

        10.4.7. Respiratory

        10.4.8. Others

    10.5. North America Geriatric Medicines Market Forecast, by Distribution Channel

        10.5.1. Hospital Pharmacies

        10.5.2. Retail Pharmacies

        10.5.3. Online Pharmacies

    10.6. North America Geriatric Medicines Market Forecast, by Country

        10.6.1. U.S.

        10.6.2. Canada

    10.7. North America Geriatric Medicines Market Attractiveness Analysis 

        10.7.1. By Therapeutic Category

        10.7.2. By Condition

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Geriatric Medicines Market Analysis

    11.1. Europe Geriatric Medicines Market Key Findings

    11.2. Europe Geriatric Medicines Market Overview

    11.3. Europe Geriatric Medicines Market Size and Forecast, by Therapeutic Category

        11.3.1. Analgesic

        11.3.2. Antihypertensive

        11.3.3. Statins

        11.3.4. Antidiabetic

        11.3.5. Proton Pump Inhibitor

        11.3.6. Anticoagulant

        11.3.7. Antipsychotic and Antidepressant 

        11.3.8. Others

    11.4. Europe Geriatric Medicines Market Size and Forecast, by Condition

        11.4.1. Cardiovascular

        11.4.2. Arthritis

        11.4.3. Diabetes

        11.4.4. Neurological

        11.4.5. Cancer

        11.4.6. Osteoporosis 

        11.4.7. Respiratory

        11.4.8. Others

    11.5. Europe Geriatric Medicines Market Forecast, by Distribution Channel

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. Europe Geriatric Medicines Market Forecast, by Country

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Spain

        11.6.5. Italy

        11.6.6. Rest of Europe

    11.7. Europe Geriatric Medicines Market Attractiveness Analysis

        11.7.1. By Therapeutic Category

        11.7.2. By Condition

        11.7.3. By Distribution Channel

        11.7.4. By Country

12. Asia Pacific Geriatric Medicines Market Analysis

    12.1. Asia Pacific Geriatric Medicines Market Key Findings

    12.2. Asia Pacific Geriatric Medicines Market Overview

    12.3. Asia Pacific Cytometry Market Size and Forecast, by Therapeutic Category

        12.3.1. Analgesic

        12.3.2. Antihypertensive

        12.3.3. Statins

        12.3.4. Antidiabetic

        12.3.5. Proton Pump Inhibitor

        12.3.6. Anticoagulant

        12.3.7. Antipsychotic and Antidepressant 

        12.3.8. Others

    12.4. Asia Pacific Geriatric Medicines Market Size and Forecast, by Condition

        12.4.1. Cardiovascular

        12.4.2. Arthritis

        12.4.3. Diabetes

        12.4.4. Neurological

        12.4.5. Cancer

        12.4.6. Osteoporosis 

        12.4.7. Respiratory

        12.4.8. Others

    12.5. Asia Pacific Geriatric Medicines Market Forecast, by Distribution Channel

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Asia Pacific Geriatric Medicines Market Forecast, by Country

        12.6.1. China

        12.6.2. India

        12.6.3. Japan

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Asia Pacific Geriatric Medicines Market Attractiveness Analysis 

        12.7.1. By Therapeutic Category

        12.7.2. By Condition

        12.7.3. By Distribution Channel

        12.7.4. By Country

13. Latin America Geriatric Medicines Market Analysis

    13.1. Latin America Geriatric Medicines Market Key Findings

    13.2. Latin America Geriatric Medicines Market Overview

    13.3. Latin America Cytometry Market Size and Forecast, by Therapeutic Category

        13.3.1. Analgesic

        13.3.2. Antihypertensive

        13.3.3. Statins

        13.3.4. Antidiabetic

        13.3.5. Proton Pump Inhibitor

        13.3.6. Anticoagulant

        13.3.7. Antipsychotic and Antidepressant 

        13.3.8. Others

    13.4. Latin America Geriatric Medicines Market Size and Forecast, by Condition

        13.4.1. Cardiovascular

        13.4.2. Arthritis

        13.4.3. Diabetes

        13.4.4. Neurological

        13.4.5. Cancer

        13.4.6. Osteoporosis 

        13.4.7. Respiratory

        13.4.8. Others

    13.5. Latin America Geriatric Medicines Market Forecast, by Country

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Geriatric Medicines Market Forecast, by Distribution Channel

        13.6.1. Hospital Pharmacies

        13.6.2. Retail Pharmacies

        13.6.3. Online Pharmacies

    13.7. Latin America Geriatric Medicines Market Attractiveness Analysis

        13.7.1. By Therapeutic Category

        13.7.2. By Condition

        13.7.3. By Distribution Channel

        13.7.4. By Country

14. Middle East & Africa Geriatric Medicines Market Analysis

    14.1. Middle East & Africa Geriatric Medicines Market Key Findings

    14.2. Middle East & Africa Geriatric Medicines Market Overview

    14.3. Middle East & Africa Cytometry Market Size and Forecast, by Therapeutic Category

        14.3.1. Analgesic

        14.3.2. Antihypertensive

        14.3.3. Statins

        14.3.4. Antidiabetic

        14.3.5. Proton Pump Inhibitor

        14.3.6. Anticoagulant

        14.3.7. Antipsychotic and Antidepressant 

        14.3.8. Others

    14.4. Middle East & Africa Geriatric Medicines Market Size and Forecast, by Condition

        14.4.1. Cardiovascular

        14.4.2. Arthritis

        14.4.3. Diabetes

        14.4.4. Neurological

        14.4.5. Cancer

        14.4.6. Osteoporosis 

        14.4.7. Respiratory

        14.4.8. Others

    14.5. Middle East & Africa Geriatric Medicines Market Forecast, by Distribution Channel

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Middle East & Africa Geriatric Medicines Market Size and Forecast, by Country

        14.6.1. GCC Countries

        14.6.2. Israel

        14.6.3. South Africa

        14.6.4. Rest of Middle East & Africa

    14.7. Middle East Geriatric Medicines Market Attractiveness Analysis

        14.7.1. By Therapeutic Category

        14.7.2. By Condition

        14.7.3. By Distribution Channel

        14.7.4. By Country

15. Competition Landscape

    15.1. Global Geriatric Medicines Market Share Analysis, by Company (2020)

    15.2. Company Profiles

        15.2.1. Pfizer, Inc.

            15.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.1.2. Financials

            15.2.1.3. Recent Developments

            15.2.1.4. Strategy

        15.2.2. Merck & Co., Inc.

            15.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.2.2. Financials

            15.2.2.3. Recent Developments

            15.2.2.4. Strategy

        15.2.3. AstraZeneca

            15.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.3.2. Financials

            15.2.3.3. Recent Developments

            15.2.3.4. Strategy

        15.2.4. Bristol-Myers Squibb Company

            15.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.4.2. Financials

            15.2.4.3. Recent Developments

            15.2.4.4. Strategy

        15.2.5. Novartis AG

            15.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.5.2. Financials

            15.2.5.3. Recent Developments

            15.2.5.4. Strategy

        15.2.6. Sanofi S.A.

            15.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.6.2. Financials

            15.2.6.3. Recent Developments

            15.2.6.4. Strategy

        15.2.7. GlaxoSmithKline plc

            15.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.7.2. Financials

            15.2.7.3. Recent Developments

            15.2.7.4. Strategy

        15.2.8. Eli Lilly and Company

            15.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.8.2. Financials

            15.2.8.3. Recent Developments

            15.2.8.4. Strategy

        15.2.9. Abbott Laboratories

            15.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.9.2. Financials

            15.2.9.3. Recent Developments

            15.2.9.4. Strategy

        15.2.10. Boehringer Ingelheim GmbH

            15.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            15.2.10.2. Financials

            15.2.10.3. Recent Developments

            15.2.10.4. Strategy

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 2: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 3: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Analgesic, 2016–2020

Table 4: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Analgesic, 2021–2031

Table 5: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antihypertensive, 2016–2020

Table 6: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antihypertensive, 2021–2031

Table 7: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Statins, 2016–2020

Table 8: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Statins, 2021–2031

Table 9: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antidiabetic, 2016–2020

Table 10: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antidiabetic, 2021–2031

Table 11: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Proton Pump Inhibitor, 2016–2020

Table 12: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Proton Pump Inhibitor, 2021–2031

Table 13: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Anticoagulant, 2016–2020

Table 14: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Anticoagulant, 2021–2031

Table 15: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Antipsychotic and Antidepressant, 2016–2020

Table 16: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Antipsychotic and Antidepressant, 2021–2031

Table 17: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Others, 2016–2020

Table 18: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Others, 2021–2031

Table 19: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 20: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 21: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Cardiovascular, 2016–2020

Table 22: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Cardiovascular, 2021–2031

Table 23: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Arthritis, 2016–2020

Table 24: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Arthritis, 2021–2031

Table 25: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Diabetes, 2016–2020

Table 26: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Diabetes, 2021–2031

Table 27: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Neurological, 2016–2020

Table 28: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Neurological, 2021–2031

Table 29: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Cancer, 2016–2020

Table 30: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Cancer, 2021–2031

Table 31: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Osteoporosis, 2016–2020

Table 32: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Osteoporosis, 2021–2031

Table 33: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Respiratory, 2016–2020

Table 34: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Respiratory, 2021–2031

Table 35: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Others, 2016–2020

Table 36: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Others, 2021–2031

Table 37: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Distribution Channel, 2016–2020

Table 38: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2031

Table 39: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2016–2020

Table 40: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Hospital Pharmacies, 2021–2031

Table 41: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2016–2020

Table 42: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Retail Pharmacies, 2021–2031

Table 43: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Online Pharmacies, 2016–2020

Table 44: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Online Pharmacies, 2021–2031

Table 45: Global Geriatric Medicines Market Size (US$ Mn) Analysis, by Region, 2016–2020

Table 46: Global Geriatric Medicines Market Size (US$ Mn) Forecast, by Region, 2021–2031

Table 47: North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 48: North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 49: North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 50: North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 51: North America Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020

Table 52: North America Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031

Table 53: Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 54: Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 55: Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 56: Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 57: Europe Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020

Table 58: Europe Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031

Table 59: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 60: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 61: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 62: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 63: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020

Table 64: Asia Pacific Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031

Table 65: Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 66: Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 67: Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 68: Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 69: Latin America Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020

Table 70: Latin America Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031

Table 71: MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Therapeutic Category, 2016–2020

Table 72: MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Therapeutic Category, 2021–2031

Table 73: MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Condition, 2016–2020

Table 74: MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Condition, 2021–2031

Table 75: MEA Geriatric Medicines Market Size (US$ Mn) Analysis, by Country, 2016–2020

Table 76: MEA Geriatric Medicines Market Size (US$ Mn) Forecast, by Country, 2021–2031

Table 77: U.S. Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 78: Canada Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 79: Brazil Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 80: Mexico Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 81: Argentina Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 82: Germany Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 83: France Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 84: Italy Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 85: Spain Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 86: U.K. Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 87: Benelux Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 88: Russia Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 89: China Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 90: Japan Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 91: South Korea Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 92: India Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 93: Thailand Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 94: Indonesia Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 95: Malaysia Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 96: Australia & New Zealand Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 97: GCC Countries Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 98: Egypt Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 99: South Africa Geriatric Medicines Market Size (US$ Mn), 2021-2031

Table 100: Turkey Geriatric Medicines Market Size (US$ Mn), 2021-2031

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Mechanical Ventilators Market Snapshot

Figure 02: Global Mechanical Ventilators Market  Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021–2031

Figure 03: Market Value Share By Product Type (2020)

Figure 04: Market Value Share By Interface  (2020)

Figure 05: Market Value Share By End User (2020)

Figure 06: Market Value Share By Region (2020)

Figure 07: Global Mechanical Ventilators Market Value Share, by Product Type, 2021 and 2031

Figure 08: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Critical Care Ventilators

Figure 09: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Neonatal Ventilators

Figure 10: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Neonatal Ventilators

Figure 11: Global Mechanical Ventilators Market Value Share, by Interface, 2021 and 2031

Figure 12: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Invasive Ventilators

Figure 13: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021–2031, by Noninvasive Ventilators

Figure 14: Global Mechanical Ventilators Market Value Share, by End-user, 2021 and 2031

Figure 15: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals and Clinics, 2021–2031

Figure 16: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgery Centres, 2021–2031

Figure 17: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gynecology Clinics, 2021–2031

Figure 18: Global Mechanical Ventilators Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2021–2031

Figure 19: Global Mechanical Ventilators Market Value Share, by Region, 2021 and 2031

Figure 20: North America Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031

Figure 21: North America Market Attractiveness Analysis, by Country

Figure 22: North America Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 23: North America Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031

Figure 24: North America Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031

Figure 25: North America Mechanical Ventilators Market Value Share Analysis, by Country, 2021 and 2031

Figure 26: Europe Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031

Figure 27: Europe Market Attractiveness Analysis, by Country

Figure 28: Europe Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 29: Europe Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031

Figure 30: Europe Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031

Figure 31: Europe Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 32: Asia Pacific Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031

Figure 33: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region

Figure 34: Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 35: Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031

Figure 36: Asia Pacific Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031

Figure 37: Asia Pacific Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 38: Latin America Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031

Figure 39: Latin America Market Attractiveness Analysis, by Country

Figure 40: Latin America Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 41: Latin America Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031

Figure 42: Latin America Mechanical Ventilators Market Value Share Analysis, by End User, 2021 and 2031

Figure 43: Latin America Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 44: Middle East & Africa Mechanical Ventilators Market Value (US$ Mn) Forecast, 2021–2031

Figure 45: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region

Figure 46: Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 47: Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Interface, 2021 and 2031

Figure 48: Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by End-user, 2021 and 2031

Figure 49: Middle East & Africa Mechanical Ventilators Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 50: Teleflex Incorporated Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 51: Teleflex Incorporated R&D Expense (%), 2016–2020

Figure 52: Teleflex Incorporated Breakdown of Net Sales, by Region, 2020

Figure 53: Teleflex Incorporated Breakdown of Net Sales, by End Market, 2020

Figure 54 : Dragerwerk AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 55 : Dragerwerk AG & Co. KGaA Breakdown of Net Sales, by Region, 2020

Figure 56 : Dragerwerk AG & Co. KGaA Marketing & Sales and R&D Expenses, 2016–2020

Figure 57: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 58: GE Healthcare Breakdown of Net Sales, by Region, 2020

Figure 59: GE Healthcare Breakdown of Net Sales, by Product Segment, 2020

Figure 60: Medtronic plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 61: Medtronic plc Marketing & Sales and R&D Expenses, 2016–2020

Figure 62: Medtronic plc Breakdown of Net Sales, by Business Segment, 2020

Figure 63:Medtronic plc Breakdown of Net Sales, by Region, 2020

Figure 64: Koninklijke Philips N.V. Breakdown of Net Sales, by Region, 2020

Figure 65: Merck & Co., Inc. Break-up of Net Sales, by Region, 2020

Figure 66: AstraZeneca Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 67: AstraZeneca Breakdown of Net Sales, by Region, 2020

Figure 68: AstraZeneca Marketing & Sales and R&D Expenses, 2016–2020

Figure 69: Bristol-Myers Squibb Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 70: Bristol-Myers Squibb Company R&D Intensity (%) - Company Level or Segment Level, 2016–2020

Figure 71: Bristol-Myers Squibb Company Breakdown of Net Sales, by Region, 2020

Figure 72: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 73: Novartis AG Marketing & Sales and R&D Expenses, 2016–2020

Figure 74: Novartis AG Breakdown of Net Sales, by Business Segment, 2020

Figure 75: Novartis AG Breakdown of Net Sales, by Region, 2020

Figure 76: Sanofi S.A. Breakdown of Net Sales, by Region, 2020

Figure 77: Sanofi S.A. Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 78: Sanofi S.A. Breakdown of Net Sales, by Business Segment, 2020

Figure 79: Sanofi S.A. R&D Intensity and Sales & Marketing Intensity (Pharmaceutical Segment) - Company Level, 2016–2020

Figure 80: GlaxoSmithKline plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2020

Figure 81: GlaxoSmithKline plc Marketing & Sales and R&D Expenses, 2016–2020

Figure 82: GlaxoSmithKline plc Breakdown of Net Sales, by Business Segment, 2020

Figure 83: GlaxoSmithKline plc Breakdown of Net Sales, by Region, 2020

Figure 84: Eli Lilly and Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 85: Eli Lilly and Company R&D Intensity (%) - Company Level or Segment Level, 2016–2020

Figure 86: Eli Lilly and Company Breakdown of Net Sales, by Region, 2020

Figure 87: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 88: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2020

Figure 89: Abbott Laboratories, Breakdown of Net Sales, by Region 2020

Figure 90: Boehringer Ingelheim GmbH, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 91: Boehringer Ingelheim GmbH, Breakdown of Net Sales, by Business Segment, 2020

Figure 92: Boehringer Ingelheim GmbH, Breakdown of Net Sales, by Region 2020

Figure 93: Boehringer Ingelheim GmbH, R&D (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Geriatric Medicines Market

Schedule a Call